The DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.
CSF1R -related leukoencephalopathy: A major player in primary microgliopathies
Open accessAbstract
Since the discovery of CSF1R gene mutations in families with hereditary diffuse leukoencephalopathy with spheroids in 2012, more than 70 different mutations have been identified around the world. Through the analyses of mutation carriers, CSF1R-related leukoencephalopathy has been distinctly characterized clinically, radiologically, and pathologically. Typically, patients present with frontotemporal dementia-like phenotype in their 40s–50s, accompanied by motor symptoms, including pyramidal and extrapyramidal signs. Women tend to develop the clinical symptoms at a younger age than men. On brain imaging, in addition to white matter abnormalities, thinning of the corpus callosum, diffusion-restricted lesions in the white matter, and brain calcifications are hallmarks. Primary axonopathy followed by demyelination was suggested by pathology. Haploinsufficiency of colony-stimulating factor-1 receptor (CSF1R) is evident in a patient with a frameshift mutation, facilitating the establishment of Csf1r haploinsufficient mouse model. These mice develop clinical, radiologic, and pathologic phenotypes consistent with those of human patients with CSF1R mutations. In vitro, perturbation of CSF1R signaling is shown in cultured cells expressing mutant CSF1R. However, the underlying mechanisms by which CSF1R mutations selectively lead to white matter degeneration remains to be elucidated. Given that CSF1R mainly expresses in microglia, CSF1R-related leukoencephalopathy is representative of primary microgliopathies, of which microglia have a pivotal and primary role in pathogenesis. In this review, we address the current knowledge of CSF1R-related leukoencephalopathy and discuss the putative pathophysiology, with a focus on microglia, as well as future research directions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“It has been discovered that autosomal dominant mutations in CSF1R, resulting in partial loss of function in CSF-1R signaling, are the major genetic cause of hereditary diffuse leukoencephalopathy with spheroids (HDLS) [22, 40, 44].”
From Loss of homeostatic microglial phenotype in CSF1R-related Leukoencephalopathy (2020) · cites this paper as [22]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Okamoto, M., Takeshita, J., Takahashi, K., Tanaka, A., Yoshida, K., & Kuriyama, M. (2017) · Rinsho Shinkeigaku · doi:10.5692/clinicalneurol.cn-001072 · Cited by 5
RetractedMicroglia in neurodegenerative disease
Perry, V. H., Nicoll, J. A. R., & Holmes, C. (2010) · Nature Reviews Neurology · doi:10.1038/nrneurol.2010.17 · Cited by 1,543
Microglia and brain macrophages in the molecular age: from origin to neuropsychiatric disease
Prinz, M., & Priller, J. (2014) · Nature Reviews Neuroscience · doi:10.1038/nrn3722 · Cited by 1,329
CSF-1 regulation of the wandering macrophage: complexity in action
Pixley, F. J., & Stanley, E. R. (2004) · Trends in Cell Biology · doi:10.1016/j.tcb.2004.09.016 · Cited by 807
Rademakers, R., Baker, M., Nicholson, A. M., Rutherford, N. J., Finch, N., Soto-Ortolaza, A., Lash, J., Wider, C., Wojtas, A., DeJesus-Hernandez, M., et al. (2012) · Nature Genetics · doi:10.1038/ng.1027 · Cited by 571
Self-citationvan der Knaap, M. S., & Bugiani, M. (2017) · Acta Neuropathologica · doi:10.1007/s00401-017-1739-1 · Cited by 403
Emerging Roles for CSF-1 Receptor and its Ligands in the Nervous System
Chiţu, V., Gökhan, Ş., Nandi, S., Mehler, M. F., & Stanley, E. R. (2016) · Trends in Neurosciences · doi:10.1016/j.tins.2016.03.005 · Cited by 365
Marras, C., Lang, A. E., van de Warrenburg, B. P. C., Sue, C. M., Tabrizi, S. J., Bertram, L., Mercimek‐Andrews, S., Ebrahimi‐Fakhari, D., Warner, T. T., Dürr, A., et al. (2016) · Movement Disorders · doi:10.1002/mds.26527 · Cited by 285
Case definition and classification of leukodystrophies and leukoencephalopathies
Vanderver, A. L., Prust, M., Tonduti, D., Mochel, F., Hussey, H. M., Helman, G., Garbern, J. Y., Eichler, F., Labauge, P. M., Aubourg, P. R., et al. (2015) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2015.01.006 · Cited by 263
Novel (ovario) leukodystrophy related to AARS2 mutations
Dallabona, C., Diodato, D., Kevelam, S. H., Haack, T. B., Wong, L.-J. C., Salomons, G. S., Baruffini, E., Melchionda, L., Mariotti, C., Strom, T. M., et al. (2014) · Neurology · doi:10.1212/wnl.0000000000000497 · Cited by 215
Konno, T., Yoshida, K., Mizuno, T., Kawarai, T., Tada, M., Nozaki, H., Ikeda, S. ‐., Nishizawa, M., Onodera, O., Wszolek, Z. K., et al. (2017) · European Journal of Neurology · doi:10.1111/ene.13125 · Cited by 179 · cited 16×
“Dr. Konno is currently with the Department of Neurology, Brain Research Institute, Niigata University, Niigata, Japan.”
BackgroundMethodInfluentialSelf-citationCSF1R mutations link POLD and HDLS as a single disease entity
Nicholson, A. M., Baker, M. C., Finch, N. A., Rutherford, N. J., Wider, C. W., Graff‐Radford, N. R., Nelson, P. T., Clark, H. B., Wszołek, Z. K., Dickson, D. W., et al. (2013) · Neurology · doi:10.1212/wnl.0b013e31828726a7 · Cited by 162
Self-citation(1984) · PubMed · Cited by 150
Marotti, J. D., Tobias, S., Fratkin, J. D., Powers, J. M., & Rhodes, C. H. (2004) · Acta Neuropathologica · doi:10.1007/s00401-004-0847-x · Cited by 139
Haploinsufficiency of CSF-1R and clinicopathologic characterization in patients with HDLS
Konno, T., Tada, M., Tada, M., Koyama, A., Nozaki, H., Harigaya, Y., Nishimiya, J., Matsunaga, A., Yoshikura, N., Ishihara, K., et al. (2013) · Neurology · doi:10.1212/wnl.0000000000000046 · Cited by 128
Self-citationLeukoencephalopathy with spheroids (HDLS) and pigmentary leukodystrophy (POLD)
Wider, C. W., van Gerpen, J. A., DeArmond, S. J., Shuster, E. A., Dickson, D. W., & Wszołek, Z. K. (2009) · Neurology · doi:10.1212/wnl.0b013e3181a826c0 · Cited by 113
Self-citationMRI characteristics and scoring in HDLS due to CSF1R gene mutations
Sundal, C., van Gerpen, J. A., Nicholson, A. M., Wider, C. W., Shuster, E. A., Aasly, J. O., Spina, S., Ghetti, B. F., Roeber, S., Garbern, J. Y., et al. (2012) · Neurology · doi:10.1212/wnl.0b013e318263575a · Cited by 113
Self-citationGenetic Analysis of Inherited Leukodystrophies
Guerreiro, R. J., Kara, E., Ber, I. L., Brás, J., Rohrer, J. D., Taipa, R. J. F., Lashley, T., Dupuits, C., Gurunlian, N., Mochel, F., et al. (2013) · JAMA Neurology · doi:10.1001/jamaneurol.2013.698 · Cited by 94
Lynch, D. S., Zhang, W. J., Lakshmanan, R., Kinsella, J. A., Uzun, G. A., Karbay, M., Tüfekçioglu, Z., Hanagasi, H., Burke, G., Foulds, N., et al. (2016) · JAMA Neurology · doi:10.1001/jamaneurol.2016.2229 · Cited by 90
Redefining the phenotype of ALSP and AARS2 mutation–related leukodystrophy
Lakshmanan, R., Adams, M. E., Lynch, D. S., Kinsella, J. A., Phadke, R., Schott, J. M., Murphy, E., Rohrer, J. D., Chataway, J., Houlden, H., et al. (2017) · Neurology Genetics · doi:10.1212/nxg.0000000000000135 · Cited by 84
Lynch, D. S., Jaunmuktane, Z., Sheerin, U., Phadke, R., Brandner, S., Milonas, I., Dean, A. F., Bajaj, N. P. S., McNicholas, N., Costello, D. J., et al. (2015) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2015-310788 · Cited by 80
Ayrignac, X., Carra-Dalliere, C., Menjot de Champfleur, N., Denier, C., Aubourg, P., Bellesme, C., Castelnovo, G., Pelletier, J., Audoin, B., Kaphan, E., et al. (2015) · Brain · doi:10.1093/brain/awu353 · Cited by 74
Sundal, C., Fujioka, S., van Gerpen, J. A., Wider, C. W., Nicholson, A. M., Baker, M. C., Shuster, E. A., Aasly, J. O., Spina, S., Ghetti, B. F., et al. (2013) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2013.05.013 · Cited by 70
Self-citationNasu–Hakola disease and primary microglial dysfunction
Bianchin, M. M., Martin, K. C., de Souza, A. C., de Oliveira, M. A., & de Mello Rieder, C. R. (2010) · Nature Reviews Neurology · doi:10.1038/nrneurol.2010.17-c1 · Cited by 69
Insights into the dynamics of hereditary diffuse leukoencephalopathy with axonal spheroids
van Gerpen, J. A., Wider, C. W., Broderick, D. F., Dickson, D. W., Brown, L., & Wszołek, Z. K. (2008) · Neurology · doi:10.1212/01.wnl.0000325916.30701.21 · Cited by 61
Self-citationKonno, T., Broderick, D. F., Mezaki, N., Isami, A., Kaneda, D., Tashiro, Y., Tokutake, T., Keegan, B. M., Woodruff, B. K., Miura, T., et al. (2016) · American Journal of Neuroradiology · doi:10.3174/ajnr.a4938 · Cited by 56
Self-citationKleinfeld, K., Mobley, B. C., Hedera, P., Wegner, A. M., Sriram, S., & Pawate, S. (2012) · Journal of Neurology · doi:10.1007/s00415-012-6680-6 · Cited by 50
Itoh, K., Shiga, K., Shimizu, K., Muranishi, M., Nakagawa, M., & Fushiki, S. (2005) · Acta Neuropathologica · doi:10.1007/s00401-005-1113-6 · Cited by 50
Ali, Z. S., van der Voorn, J. P., & Powers, J. M. (2007) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e3180986247 · Cited by 49
Bender, B., Klose, U., Lindig, T. M., Biskup, S., Nägele, T., Schöls, L. J., & Karle, K. N. (2014) · Journal of Neurology · doi:10.1007/s00415-014-7509-2 · Cited by 48
Mateen, F. J., Keegan, B. M., Krecke, K. N., Parisi, J. E., Trenerry, M. R., & Pittock, S. J. (2010) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2008.169243 · Cited by 47
Saitoh, B., Yamasaki, R., Hayashi, S., Yoshimura, S., Tateishi, T., Ohyagi, Y., Murai, H., Iwaki, T., Yoshida, K., & Kira, J. (2013) · Multiple Sclerosis Journal · doi:10.1177/1352458513489854 · Cited by 47
Sundal, C., Baker, M., Karrenbauer, V. D., Gustavsen, M. W., Bedri, S. K., Glaser, A., Myhr, K.-M., Haugarvoll, K., Zetterberg, H., Harbo, H. F., et al. (2014) · European Journal of Neurology · doi:10.1111/ene.12572 · Cited by 46
Kim, E., Shin, J., Lee, J. H., Kim, J. H., Na, D. L., Suh, Y., Hwang, S. J., Lee, J., Lee, Y. M., Shin, M., et al. (2014) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2014.12.021 · Cited by 43
Inui, T., Kawarai, T., Fujita, K., Kawamura, K., Mitsui, T., Orlacchio, A., Kamada, M., Abe, T., Izumi, Y., & Kaji, R. (2013) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2013.08.020 · Cited by 37
Terasawa, Y., Osaki, Y., Kawarai, T., Sugimoto, T., Orlacchio, A., Abe, T., Izumi, Y., & Kaji, R. (2013) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2013.08.027 · Cited by 36
Novel AARS2 gene mutation producing leukodystrophy: a case report
Szpisjak, L., Zsindely, N., Engelhardt, J. I., Vécsei, L., Kovács, G. G., & Klivènyi, P. (2016) · Journal of Human Genetics · doi:10.1038/jhg.2016.126 · Cited by 33
Battisti, C., Donato, I. D., Bianchi, S., Monti, L., Formichi, P., Rufa, A., Taglia, I., Cerase, A., Dotti, M. T., & Federico, A. (2014) · Journal of Neurology · doi:10.1007/s00415-014-7257-3 · Cited by 32
Hoffmann, S., Murrell, J. R., Harms, L., Miller, K., Meisel, A., Brosch, T., Scheel, M., Ghetti, B. F., Goebel, H., & Stenzel, W. (2014) · Brain Pathology · doi:10.1111/bpa.12120 · Cited by 32
CSF1R-related leukoencephalopathy mimicking primary progressive multiple sclerosis
Prieto-Morin, C., Ayrignac, X., Ellie, E., Tournier‐Lasserve, E., & Labauge, P. M. (2016) · Journal of Neurology · doi:10.1007/s00415-016-8197-x · Cited by 30
A novel mutation in the CSF1R gene causes a variable leukoencephalopathy with spheroids
Piana, R. L., Webber, A., Guiot, M., Cortes, M. D. P., & Brais, B. (2014) · Neurogenetics · doi:10.1007/s10048-014-0413-1 · Cited by 28
Ikeuchi, T., Mezaki, N., & Miura, T. (2017) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2017.08.018 · Cited by 24
Self-citationFujioka, S., Broderick, D. F., Sundal, C., Baker, M., Rademakers, R., & Wszołek, Z. K. (2013) · Journal of Neurology · doi:10.1007/s00415-013-7093-x · Cited by 23
Donato, I. D., Stabile, C., Bianchi, S., Taglia, I., Mignarri, A., Salvatore, S., Giorgio, E., Brusco, A., Simone, I. L., Dotti, M. T., et al. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-150097 · Cited by 17
Shu, Y., Long, L., Liao, S., Yang, J., Li, J., Qiu, W., Yang, Y., Bao, J., Wu, A., Hu, X., et al. (2016) · BMC Neurology · doi:10.1186/s12883-016-0694-0 · Cited by 17
Comprehensive diagnostics in a case of hereditary diffuse leukodystrophy with spheroids
Meyer-Ohlendorf, M., Braczynski, A. K., Al-Qaisi, O., Gessler, F. A., Biskup, S., Weise, L. M., Steinbach, J., Wagner, M., Mittelbronn, M. G. A., & Bähr, O. (2015) · BMC Neurology · doi:10.1186/s12883-015-0368-3 · Cited by 14
Diffuse leukoencephalopathy with spheroids presenting as primary progressive aphasia
Oboudiyat, C., Bigio, E. H., Bonakdarpour, B., Baker, M. C., Rademakers, R., Weıntraub, S., & Mesulam, M. M. (2015) · Neurology · doi:10.1212/wnl.0000000000001851 · Cited by 14
CSF1R Mutation p.G589R and the Distribution Pattern of Brain Calcification
Daida, K., Nishioka, K., Li, Y., Nakajima, S., Tanaka, R., & Hattori, N. (2017) · Internal Medicine · doi:10.2169/internalmedicine.8462-16 · Cited by 14
A young-onset frontal dementia with dramatic calcifications due to a novel CSF1R mutation
Gore, E., Manley, A. T., Dees, D., Appleby, B. S., & Lerner, A. J. (2016) · Neurocase · doi:10.1080/13554794.2016.1175635 · Cited by 13
Kimura, T., Ishizawa, K., Mitsufuji, T., Abe, T., Nakazato, Y., Yoshida, K., Sasaki, A., & Araki, N. (2013) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12046 · Cited by 12
Kitani‐Morii, F., Kasai, T., Tomonaga, K., Saito, K., Mizuta, I., Yoshioka, A., Nakagawa, M., & Mizuno, T. (2014) · Internal Medicine · doi:10.2169/internalmedicine.53.1932 · Cited by 12
Wu, L., Liu, J., Sha, L., Wang, X., Li, J., Dong, J., & Jia, J. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-161193 · Cited by 11
Fernández‐Vega, I., de Heredia-Goñi, K. P., Santos‐Juanes, J., Goñi-Imízcoz, M., Zaldumbide, L., Zarranz, J. J., & Ferrer, I. (2015) · Histopathology · doi:10.1111/his.12741 · Cited by 10
Saitoh, B., Yoshida, K., Hayashi, S., Yamasaki, R., Sato, S., Kamada, T., Suzuki, S. O., Murai, H., Iwaki, T., Ikeda, S., et al. (2013) · Clinical and Experimental Neuroimmunology · doi:10.1111/cen3.12076 · Cited by 8
Leukodystrophy or genetic leukoencephalopathy? Nature does not make leaps
Salsano, E. (2015) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2015.02.005 · Cited by 6
Suspected Perinatal Depression Revealed to be Hereditary Diffuse Leukoencephalopathy with Spheroids
Waldthaler, J., & Weissert, R. (2016) · Journal of Movement Disorders · doi:10.14802/jmd.16050 · Cited by 6
Brain calcification in a CSF1R mutation carrier precedes white matter degeneration
Konno, T., Broderick, D. F., & Wszołek, Z. K. (2017) · Movement Disorders · doi:10.1002/mds.27130 · Cited by 6
Self-citationThe First Neuropathological Studies on HDLS
Röyttä, M. (2015) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0000000000000206 · Cited by 4
Research works printed but not linked: 2
- Van Bogaert L, Nyssen R. Le type tardif de la leukodystrophie progressive familiale. Rev Neurol 1936;65:21–45.
- Imai T, Kato B, Ohshima J, Hasegawa Y. Hereditary diffuse leukoencephalopathy with spheroids (HDLS) carrying a novel CSF1R mutation (p.Phe758Ser) with characteristic brain calcifications: a case report. Neurol Med 2017;87:670–675.
Cited by
Sorted by citations
Tissue-specific macrophages: how they develop and choreograph tissue biology
Mass, E., Nimmerjahn, F., Kierdorf, K., & Schlitzer, A. (2023) · Nature Reviews Immunology · doi:10.1038/s41577-023-00848-y · Cited by 621
The M-CSF receptor in osteoclasts and beyond
Mun, S. H., Park, P. S. U., & Park‐Min, K. (2020) · Experimental & Molecular Medicine · doi:10.1038/s12276-020-0484-z · Cited by 257
Uncovering sex differences of rodent microglia
Han, J., Fan, Y., Zhou, K., Blomgren, K., & Harris, R. A. (2021) · Journal of Neuroinflammation · doi:10.1186/s12974-021-02124-z · Cited by 224
Laurindo, L. F., Dias, J. A., Araújo, A. C., Pomini, K. T., Galhardi, C. M., Detregiachi, C. R. P., Haber, L. S. D. A., Roque, D. D., Bechara, M. D., de Castro, M. V. M., et al. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1305933 · Cited by 158
Phenotypic impacts of CSF1R deficiencies in humans and model organisms
Hume, D. A., Caruso, M., Ferrari-Cestari, M., SUMMERS, K. M., Pridans, C., & Irvine, K. M. (2019) · Journal of Leukocyte Biology · doi:10.1002/jlb.mr0519-143r · Cited by 127
Metadata
- Authors
- Konno, T., Kasanuki, K., Ikeuchi, T., Dickson, D. W., & Wszolek, Z. K.
- Affiliations
- Mayo Clinic (US)
- From the Departments of Neurology (T.K., Z.K.W.) and Neuroscience (K.K., D.W.D.), Mayo Clinic, Jacksonville, FL; and Department of Molecular Genetics (T.I.), Brain Research Institute, Niigata University, Niigata, Japan. Dr. Konno is currently with the Department of Neurology, Brain Research Institute, Niigata University, Niigata, Japan.
- Venue
- Neurology
- Published
- 2018-12-11
- Volume
- 91
- Issue
- 24
- Pages
- 1092-1104
- ISSN
- 0028-3878 (ISSN-L)
- 1526-632X
- PMC
- PMC6329328
- OpenAlex
- W2901193227
- Cited by
- 208
- References
- 58
- Citations by year
- 2026: 20 · 2025: 27 · 2024: 40 · 2023: 30 · 2022: 27 · 2021: 34 · 2020: 19 · 2019: 10
- FWCI
- 1.49
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Neurology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Health Sciences › Medicine › Clinical Neurology › Cerebrovascular and genetic disorders
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Hereditary Neurological Disorders
- Keywords
- CSF1R-related leukoencephalopathy, CSF1R mutation, hereditary diffuse leukoencephalopathy with spheroids, haploinsufficiency, microglia, white matter degeneration, demyelination, frontotemporal dementia, corpus callosum thinning, cerebral calcification, CSF1R signaling, mouse model, pathophysiology
- MeSH terms
- Animals, Brain, Humans, Mutation, Receptor, Macrophage Colony-Stimulating Factor, Receptors, Granulocyte-Macrophage Colony-Stimulating Factor, Microglia, Leukoencephalopathies
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
